SARS-CoV-2感染后的18F-FDG脑PET代谢减低:持续性/迟发性障碍的基础?
本文回顾性分析了两例确诊SARS-CoV-2感染患者在病毒感染后阶段的临床检查及全脑基于体素的18F-FDG PET代谢分析(与健康受试者比较,p voxel < 0.001,p-cluster < 0.05,未校正)。两例患者均发现嗅区/直回代谢减低,其中一例嗅区减退持续4周者尤为明显;另一例主诉迟发性疼痛综合征的患者还出现杏仁核、海马、海马旁回、扣带回、中央前/后回、丘脑/下丘脑、小脑、脑桥和延髓的额外代谢减低。作者认为这些初步发现支持SARS-CoV-2经嗅球神经侵袭并可能扩展至其他脑结构的假说,18F-FDG PET代谢减低或可作为该受累的脑定量生物标志物,尚需病毒后队列研究明确其与持续性障碍的关系。
要点
- 两例SARS-CoV-2感染后患者均见嗅区/直回18F-FDG代谢减低。
- 一例嗅区减退持续4周者嗅区/直回代谢减低尤为明显。
- 另一例迟发性疼痛综合征者另见边缘系统、脑干等多处代谢减低。
核心结论
- 这些初步发现支持SARS-CoV-2经嗅球神经侵袭并可能扩展至其他脑结构的假说。
- 18F-FDG PET代谢减低或可作为该受累的脑定量生物标志物。
- 尚需病毒后队列研究明确这些代谢减低与可能持续性障碍(尤其认知或情绪障碍、残留呼吸症状或疼痛主诉)的确切关系。
研究设计与样本
- 研究类型为对两例确诊SARS-CoV-2感染患者在病毒感染后阶段进行的临床检查回顾及全脑基于体素的18F-FDG PET代谢分析,并与健康受试者比较(p voxel < 0.001,p-cluster < 0.05,未校正)。
主要发现
- 两例患者均发现嗅区/直回代谢减低,其中一例嗅区减退持续4周者尤为明显。
- 另一例主诉迟发性疼痛综合征的患者还发现杏仁核、海马、海马旁回、扣带回、中央前/后回、丘脑/下丘脑、小脑、脑桥和延髓的额外代谢减低。
关键数值与推荐
- 全脑基于体素的18F-FDG PET代谢分析采用p voxel < 0.001、p-cluster < 0.05(未校正)与健康受试者比较。
局限性
- 原文结论指出这些为初步发现(preliminary findings)。
- 原文结论指出尚需病毒后队列研究以明确代谢减低与可能持续性障碍的确切关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Several brain complications of SARS-CoV-2 infection have been reported. It has been moreover speculated that this neurotropism could potentially cause a delayed outbreak of neuropsychiatric and neurodegenerative diseases of neuroinflammatory origin. A propagation mechanism has been proposed across the cribriform plate of the ethmoid bone, from the nose to the olfactory epithelium, and possibly afterward to other limbic structures, and deeper parts of the brain including the brainstem. METHODS: Review of clinical examination, and whole-brain voxel-based analysis of 18F-FDG PET metabolism in comparison with healthy subjects (p voxel < 0.001, p-cluster < 0.05, uncorrected), of two patients with confirmed diagnosis of SARS-CoV-2 explored at the post-viral stage of the disease. RESULTS: Hypometabolism of the olfactory/rectus gyrus was found on the two patients, especially one with 4-week prolonged anosmia. Additional hypometabolisms were found within amygdala, hippocampus, parahippocampus, cingulate cortex, pre-/post-central gyrus, thalamus/hypothalamus, cerebellum, pons, and medulla in the other patient who complained of delayed onset of a painful syndrome. CONCLUSION: These preliminary findings reinforce the hypotheses of SARS-CoV-2 neurotropism through the olfactory bulb and the possible extension of this impairment to other brain structures. 18F-FDG PET hypometabolism could constitute a cerebral quantitative biomarker of this involvement. Post-viral cohort studies are required to specify the exact relationship between such hypometabolisms and the possible persistent disorders, especially involving cognitive or emotion disturbances, residual respiratory symptoms, or painful complaints.
引用
- Guedj E, Million M, Dudouet P, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2020. PMID: 32728799. doi:10.1007/s00259-020-04973-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。